LEXXW Lexaria Bioscience Corp.
—Mkt Cap: —P/E: —266d ago
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific…
Industry Peers
Food & Staples RetailingKey Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)194.00K USD
Gross Profit703.20K USD
Net Income (TTM)-11.90M USD
Revenue/Share0.13 USD
Last Price—
Fiscal Year End—
MR Quarter—
Employees7
CountryUS
SectorConsumer Defensive
IndustryFood & Staples Retailing
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)—
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin99.61%
Oper. Margin-3862.94%
EBITDA Margin0.00%
Profit Margin-1686.00%
ROE-398.10%
ROA-285.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.45M USD
CapEx (TTM)99.75K USD
FCF Margin-2416.61%
FCF Yield—
Net Debt-3.53M USD
Net Debt/EBITDA0.48
Balance Sheet
Debt/Equity0.04
Current Ratio10.60
Quick Ratio9.56
Book Value/Sh2.87 USD
Cash/Share2.19 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float1.60M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.49
S&P 52W Chg14.58%
Avg Vol (30d)—
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—